You need to enable JavaScript to run this app.
Regulatory Recon: FDA Delays Decision on Sarepta DMD Drug Novo Diabetes Combo Gets Unanimous Support at AdComm (25 May 2016)
Recon
Regulatory News
Michael Mezher
Recon
Regulatory NewsMichael Mezher
ReconRegulatory NewsMichael Mezher